ZNTL

Zentalis Pharmaceuticals, Inc.

4.420

+1.660+60.14%

After Hours: 4.469 +0.049 +1.10%19:59 04/09 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.020/2.760

TODAY RANGE2.850-4.500

VOL15.87M

MARKET CAP313.52M

52 WEEK RANGE1.010-4.500

AVG VOL (3M)1.03M

% TURNOVER22.38%

TURNOVER--

P/E (TTM)-2.3177

% RANGE59.29%

EPS(TTM)-1.9071

P/E(FORWARD)-2.1881

P/B1.412

BVPS3.130

DIVIDEND--

P/S2.220

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP242.14M

SHARES OUTSTANDING70.93M

NEXT EARNINGS05/12-05/18

FREE FLOAT54.78M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·11h ago
Zentalis Pharmaceuticals Climbs on Selection of Higher Dose for Ovarian-Cancer Trials
TipRanks·13h ago
H.C. Wainwright Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)
TipRanks·16h ago
Zentalis Advances Azenosertib Dose in DENALI Phase 2
Reuters·17h ago
Zentalis picks 400 mg azenosertib dose for pivotal ovarian cancer trials
Reuters·17h ago
ZENTALIS PHARMACEUTICALS INC - DENALI PART 2C COHORT ENROLLMENT PLANNED FOR Q2 2026
Reuters·04/01 21:00
Zentalis grants inducement stock options for 36,000 shares to new hires
Reuters·04/01 21:00
ZENTALIS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
TipRanks·03/28 03:56
Wedbush Keeps Their Hold Rating on Zentalis Pharmaceuticals (ZNTL)
TipRanks·03/28 03:55
Advancing Azenosertib Pipeline and DENALI Readouts Underpin Buy Rating on Zentalis Pharmaceuticals
NASDAQ·03/27 18:13
Friday Sector Laggards: Manufacturing, Biotechnology Stocks
TipRanks·03/27 16:30
Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX), Zentalis Pharmaceuticals (ZNTL) and Autolus Therapeutics (AUTL)
Dow Jones·03/27 12:57
Zentalis Pharmaceuticals Price Target Maintained With a $6.00/Share by Guggenheim
TipRanks·03/27 12:35
Zentalis Pharmaceuticals (ZNTL) Receives a Buy from Oppenheimer
TipRanks·03/27 10:30
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Nuvation Bio (NUVB) and BioAge Labs, Inc. (BIOA)
Seeking Alpha·03/26 20:33
Zentalis Pharmaceuticals GAAP EPS of -$1.91

Same Industry

Name/Symbol

Change%

Price

ZNTL

Regeneron Pharmaceuticals

REGN

+0.16%

763.04

GRDX

BIONTECH

BNTX

+1.97%

91.18

United Therapeutics Corp.

UTHR

-0.64%

577.97

Siga Technologie

SIGA

+1.35%

5.24

Vertex Pharmaceuticals Inc

VRTX

-1.91%

438.71

Moderna

MRNA

-1.66%

49.20

Charles Riv Labs Intl Inc

CRL

-0.58%

173.89

Medpace Holdings

MEDP

+1.81%

498.34

Talphera Inc

TLPH

+2.81%

0.8122

ICON PLC

ICLR

+2.49%

114.19

China Biologic

CBPO

0.00%

119.99

IQV

MOLECULAR PARTNERS AG

MOLN

-3.87%

3.850

Gilead Sciences Inc

GILD

+0.30%

140.13

ARCT

PRA Health

PRAH

0.00%

165.21

APVO

INCY

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.